SCHEMBL21035343

SCHEMBL21035343

CC(C)(C)OC(=O)NC1CCN(C(=O)[C@@H]2CN(Cc3ccc(-c4ccc(Cl)cc4)cc3)CCN2S(=O)(=O)c2ccc3cc(OC4CCCC4)ccc3c2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 5/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ROCK2 O75116 1/20 0.39
MMP1 P03956 2/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
PARP1 P09874 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
MCHR1 Q99705 2/20 0.36
KCNH2 Q12809 1/20 0.36
PRKAA2 P54646 3/20 0.36
GHSR Q92847 1/20 0.35
HTR1A P08908 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035072 1.00 CCR4 (0.42) CCR4MEN1KMT2AROCK2MMP1
SCHEMBL21035330 1.00 CCR4 (0.42) CCR4MEN1KMT2AROCK2MMP1
SCHEMBL21036232 0.92 CCR4 (0.38) CCR4KMT2AROCK2MMP1MMP9
SCHEMBL21036186 0.92 CCR4 (0.38) CCR4KMT2AROCK2MMP1MMP9
SCHEMBL21035093 0.92 CCR4 (0.38) CCR4KMT2AROCK2MMP1MMP9
SCHEMBL21034935 0.91 CCR4 (0.42) CCR4ROCK2MMP1MMP9MMP13
SCHEMBL21036254 0.88 CCR4 (0.40) CCR4ROCK2MMP1MMP9MMP13
SCHEMBL21035452 0.88 CCR4 (0.40) CCR4ROCK2MMP1MMP9MMP13
SCHEMBL21035531 0.87 ITGB1 (0.38) CCR4MEN1KMT2AKCNH2GHSR
SCHEMBL21035112 0.87 ITGB1 (0.38) CCR4MEN1KMT2AKCNH2GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed